Antiretrovirals
Paediatric formulation of fosamprenavir approved in Europe
On 13 September, the EMEA issued a decision to extend the indication for fosamprenavir (Telzir) in combination with ritonavir to include adolescents and children of six years and older.
Telzir – EMEA European Public Assessment Report (includes full prescribing information)
http://www.emea.europa.eu/humandocs/Humans/EPAR/telzir/telzir.htm
Telzir – EMEA scientific opinion for approval PDF
http://www.emea.europa.eu/humandocs/PDFs/EPAR/telzir/EMEA-H-534-II-18-AR.pdf
Source: GSK press release.
Links to external websites are current at time of posting but not maintained.